Innovate CORP

Market Movers (8-K)

NYSE
Innovate Corp. has entered into supplemental indentures to modify interest payment terms on its senior secured notes, allowing for payment-in-kind interest and extending a promissory note maturity.
Delay expected
NYSE
Innovate Corp. announced that its subsidiary, DBM Global Inc., will pay a cash dividend of approximately $12 million, with Innovate Corp. expecting to receive about $11 million.
NYSE
Innovate Corp. shareholders approved all management proposals at the 2026 Annual Meeting, including director elections and equity plan amendments.
NYSE
Innovate Corp. announced the successful closing of a refinancing transaction for its broadcasting subsidiary and an agreement to sell a controlling interest in that subsidiary to CONX Corp.
Capital raise
NYSE
INNOVATE Corp. reported a 33% increase in first-quarter revenue to $364.8 million, driven by its Infrastructure segment, while also achieving key regulatory milestones in Life Sciences.
Better than expected
NYSE
INNOVATE Corp. announced that its subsidiary, DBM Global Inc., will pay a $3 million cash dividend, with INNOVATE receiving approximately $2.7 million.

Quarterly Earnings (10-Q)

NYSE
Innovate Corp. reported a significant increase in revenue for the first quarter of 2026, driven by its Infrastructure segment, but continues to face substantial doubt regarding its ability to continue as a going concern due to significant debt obligations.
Delay expected
Worse than expected
Capital raise
NYSE
INNOVATE Corp. reports mixed Q3 2025 results, with revenue growth in Infrastructure but increased net losses for the nine-month period, while addressing substantial doubt about its ability to continue as a going concern through extensive debt refinancing and planned asset sales.
Worse than expected
Delay expected
Capital raise
NYSE
INNOVATE Corp. reported a significant net loss for Q2 2025, driven by decreased revenue in its Infrastructure segment and rising interest expenses, despite recent debt refinancing efforts.
Worse than expected
Capital raise
NYSE
Innovate Corp. reports a decrease in revenue and an increased net loss for Q1 2025, while also expressing substantial doubt about its ability to continue as a going concern.
Capital raise
Worse than expected
NYSE
Innovate Corp. reports a decrease in revenue for Q3 2024, alongside ongoing efforts to address debt obligations and improve financial stability.
Worse than expected
Capital raise
NYSE
Innovate Corp. experienced a decrease in revenue but an increase in income from operations in the second quarter of 2024, while also completing a rights offering and private placement.
Worse than expected
Capital raise

Annual Reports (10-K)

NYSE
INNOVATE Corp. reported a significant net loss in 2025 and faces substantial doubt about its ability to continue as a going concern, prompting strategic asset sales and debt refinancing efforts.
Worse than expected
Capital raise
Delay expected
NYSE
INNOVATE Corp. files its 10-K, detailing financial results for the year ended December 31, 2024, while addressing concerns about its ability to continue as a going concern and outlining strategic initiatives.
Worse than expected
Capital raise
NYSE
R2 Technologies amended its senior secured promissory notes, securing $20 million in financing, while Innovate Corp. filed its annual 10-K report detailing financial results and strategic initiatives.
Worse than expected
Capital raise

Insider Trading (Form 4)

NYSE
INNOVATE Corp.'s Chief Financial Officer, Michael J. Sena, reported tax-related dispositions of common stock following restricted stock vesting.
NYSE
An amendment to a Form 4 filing by Avram A. Glazer and related entities discloses Lancer Capital LLC as an additional reporting owner of INNOVATE Corp. convertible notes.
NYSE
INNOVATE Corp.'s Interim CEO, Paul Voigt, reported the acquisition of 100,000 stock options and updated his beneficial ownership.
NYSE
INNOVATE Corp.'s Interim CEO, Paul Voigt, was granted 176,056 shares of restricted common stock valued at approximately $1 million.
NYSE
INNOVATE Corp. exchanged $2.0 million in 2026 convertible notes for $2.195 million in 2027 notes with Lancer Capital, a related party.
NYSE
INNOVATE Corp. Director Amy Marie Wilkinson was granted 16,363 shares of restricted common stock as part of an equity award plan, increasing her beneficial ownership to 46,904 shares, adjusted for a recent reverse stock split.

Proxy Statements (Def-14A)

NYSE
INNOVATE Corp. has announced its 2026 Annual Meeting of Stockholders, to be held virtually on June 11, 2026, with key proposals including director elections and equity plan amendments.
NYSE
INNOVATE Corp. has filed a definitive proxy statement with the Securities and Exchange Commission.
NYSE
INNOVATE Corp. will hold its 2025 Annual Meeting virtually on June 12, 2025, to vote on director elections, executive compensation, and auditor ratification.
Capital raise
NYSE
Innovate Corp. has amended its equity award plan to increase the number of shares available for issuance, aiming to attract and retain key personnel.
NYSE
INNOVATE Corp.'s annual stockholder meeting was adjourned due to technical difficulties and will be reconvened on June 18, 2024.
Delay expected
NYSE
INNOVATE Corp. files a supplement to its definitive proxy statement to correct an inadvertent error in the Second Amended and Restated 2014 Omnibus Equity Award Plan.

Schedule 13G - Passive Investments

NYSE
Whitefort Capital Management, LP, along with its co-managing partners, reported a 7.8% beneficial ownership stake in INNOVATE Corp., totaling 1,059,897 shares.
NYSE
Whitefort Capital Management, along with its co-managing partners David Salanic and Joseph Kaplan, have reported a 7.6% beneficial ownership stake in INNOVATE Corp.